Mitchell Sinkler & Starr Continues to Hold Position in Novartis AG
Mitchell Sinkler & Starr held its stake in shares of Novartis AG during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The hedge fund owned 3,596 shares of the company's stock at the end of the fourth quarter.
from Biotech News
0 Comments